Erratum: ESHRE guideline: ovarian stimulation for IVF/ICSI.

[This corrects the article DOI: 10.1093/hropen/hoaa009.][This corrects the article DOI: 10.1093/hropen/hoaa009.].

Human Reproduction Open, Volume 2020, Issue 2, 2020, hoaa009, https://doi.org/10.1093/hropen/hoaa009

Oxford University Press would like to apologise to the Authors and readers for the introduction of two errors into this paper during the Production of the final version.

In the version published online on 01 May 2020 the text recommended that progesterone administration for luteal support after IVF/ICSI is conditional when this should be a strong recommendation. The correct recommendation is:

The following recommendation was adjusted, although the recommendation remains correct, the GRADE mark format was altered. The correct recommendation is:

Further an extra z was added to the following recommendation although the recommendation remains correct. The correct recommendation is:

Progesterone is recommended for luteal phase support after IVF/ICSI. (van der Linden et al., 2015)

Strong ⊕◯◯◯

In urgent (oncology) fertility preservation cycles, random-start OS is an important option. (Boots et al., 2016)

Conditional ⊕⊕◯◯

The association of follicle size as a triggering criterion with outcome has not been sufficiently studied. Physicians may choose the follicle size upon which final oocyte maturation is triggered on a case to case basis. (Chen et al., 2014)

Conditional ⊕⊕◯◯